Compounds > 3,4-dihydroxyphenylacetic acid

3,4-dihydroxyphenylacetic acid and 4-hydroxy-2-nonenal

3,4-dihydroxyphenylacetic acid has been researched along with 4-hydroxy-2-nonenal in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (50.00)	29.6817
2010's	3 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anderson, DG; Brogden, NK; Doorn, JA; Florang, VR; Hurley, TD; Rees, JN	1
Anderson, DG; Doorn, JA; Florang, VR; Rees, JN	1
Anderson, DG; Doorn, JA; Florang, VR; Jinsmaa, Y; Rees, JN; Strack, S	1
Casida, JE; Cooney, A; Ford, B; Goldstein, DS; Jinsmaa, Y; Sullivan, P	1
Bubacco, L; Plotegher, N	1
Anderson, EJ; Builta, ZJ; Doorn, JA; Monroe, TB; Nelson, MM	1

Reviews

1 review(s) available for 3,4-dihydroxyphenylacetic acid and 4-hydroxy-2-nonenal

Article	Year
Lysines, Achilles' heel in alpha-synuclein conversion to a deadly neuronal endotoxin. Ageing research reviews, 2016, Volume: 26 Topics: 3,4-Dihydroxyphenylacetic Acid; Aldehydes; alpha-Synuclein; Brain; Dopamine; Humans; Lysine; Metabolism; Neurodegenerative Diseases; Neurons	2016

Other Studies

5 other study(ies) available for 3,4-dihydroxyphenylacetic acid and 4-hydroxy-2-nonenal

Article	Year
Inhibition of the oxidative metabolism of 3,4-dihydroxyphenylacetaldehyde, a reactive intermediate of dopamine metabolism, by 4-hydroxy-2-nonenal. Neurotoxicology, 2007, Volume: 28, Issue:1 Topics: 3,4-Dihydroxyphenylacetic Acid; Aldehyde Dehydrogenase; Aldehyde Reductase; Aldehydes; Animals; Chromatography, High Pressure Liquid; Dopamine; Half-Life; Humans; Mitochondria; Oxidation-Reduction; Oxidative Stress; Rats; Rats, Sprague-Dawley	2007
Lipid peroxidation products inhibit dopamine catabolism yielding aberrant levels of a reactive intermediate. Chemical research in toxicology, 2007, Volume: 20, Issue:10 Topics: 3,4-Dihydroxyphenylacetic Acid; Aldehydes; Animals; Corpus Striatum; Cross-Linking Reagents; Dopamine; Dose-Response Relationship, Drug; Drug Antagonism; Enzyme Inhibitors; Lipid Peroxidation; Malondialdehyde; Oxidative Stress; Rats; Rats, Sprague-Dawley; Synaptosomes	2007
Products of oxidative stress inhibit aldehyde oxidation and reduction pathways in dopamine catabolism yielding elevated levels of a reactive intermediate. Chemical research in toxicology, 2009, Volume: 22, Issue:5 Topics: 3,4-Dihydroxyphenylacetic Acid; Aldehyde Reductase; Aldehydes; Animals; Dopamine; Lipid Peroxidation; Malondialdehyde; Oxidation-Reduction; Oxidative Stress; PC12 Cells; Phenylethyl Alcohol; Rats	2009
Benomyl, aldehyde dehydrogenase, DOPAL, and the catecholaldehyde hypothesis for the pathogenesis of Parkinson's disease. Chemical research in toxicology, 2014, Aug-18, Volume: 27, Issue:8 Topics: 3,4-Dihydroxyphenylacetic Acid; Aldehyde Dehydrogenase; Aldehydes; Animals; Antifungal Agents; Benomyl; Cell Line; Enzyme Inhibitors; Humans; Lipid Peroxidation; Mice; Parkinson Disease; PC12 Cells; Rats	2014
Biochemical characterization of the catecholaldehyde reactivity of L-carnosine and its therapeutic potential in human myocardium. Amino acids, 2019, Volume: 51, Issue:1 Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Aldehydes; Carnosine; Catechols; Cysteine; Glutathione; Humans; Middle Aged; Mitochondria; Myocardium; Oxidation-Reduction	2019